6.3. Agilent HP-5MS UI (equivalent to (5%-Phenyl)-methylpolysiloxane), 30 m x 0.25 mm x 0.25 m -used for first dimension of GCxGC TOF-MS analysis. 6.4. Restek Rxi®-17Sil MS (fused silica), 1 m x 0.18 mm x 0.18 m -used for second dimension of GCxGC TOF-MS analysis. 6.5. Phenomenex Strata SAX Solid Phase Extraction Cartridges (500 mg, 3 mL). 6.6. Methanol, HPLC Grade. 6.7. Acetonitrile, HPLC Grade. 6.8. Acetic acid, ACS Grade. 6.9. Trifluoroacetic Acid (Aldrich, 99%) 6.10. Triethylamine (Aldrich, 99.5%) 6.11. Pentafluorobenzyl bromide (Aldrich, 99%) 6.12. Water, HPLC grade 6.13. Pooled human urine (Innovative Research) 6.14. Protonated and deuterated phosphonic acids (Cerilliant; see Section 8)
SAMPLE COLLECTION, PRESERVATION AND HANDLING:
Samples should be frozen at -80°C as soon as possible after collection and brought slowly to room temperature immediately before analysis. Method development samples are spiked with the protonated and deuterated phosphonic acids in house. All handling and transportation will be in accordance with the LLNL chemical warfare agent and BSL-2 safety procedures.
STANDARDS AND CONTROLS:
8.1. Protonated phosphonic acids: methyl phosphonic acid (MPA, ERM-038), ethyl methylphosphonic acid (EMPA, ERE-024), isopropyl methylphosphonic acid (IMPA, ERI-015), pinacolyl methylphosphonic acid (PMPA, ERP-083) (Cerilliant standards) 8.2. Isotopically labelled phosphonic acids as internal standards:
13 CD 3 -Methylphosphonic acid (CDLM-6100-1.2) D 5 -ethyl methylphosphonic acid (DLM-6098-1.2), D 7 -isopropyl methylphosphonic acid (ERI-017), 13 C 6 -pinacolyl methylphosphonic acid (CLM-6620-1.2 ) (Cerilliant standards) 9. CALIBRATION: 9.1. Perfluorotributylamine (PFTBA) mass spectrometer tune solution.
SAMPLING:
This method was developed using pooled urine samples prepared by the following spiking procedure:
10.1. Aliquot a known volume of urine into a glass vial. 10.2. Known amounts of phosphonic acids were spiked in the urine sample. 10.3. Sample vortexed to thoroughly combine sample before extraction. 12.3.1.5. Wash with 6 mL of methanol. 12.3.1.6. Elute sample using 5 mL of 1% trifluoroacetic acid in acetonitrile. 12.4. Dry captured elutant to complete dryness using a gentle stream of nitrogen gas. 12.5. Add 300 μL of acetone and vortex for 60 seconds. 12.6. Add 5 μL of triethylamine and 5 μL of pentafluorobenzyl bromide. 12.7. Vortex for 60 seconds and heat for one hour at 70°C. 12.8. Reduce final volume to approximately 100 μL for analysis using gentle stream of nitrogen gas. 
OTHER QUALITY ASSURANCE CONSIDERATIONS:
where: A u = Measured peak area of the isotopically labelled phosphonic acid in the urine sample. A cal = Average measured peak area of the isotopically labelled phosphonic acid of the calibration sample set.
12.14. Data Quantitation 12.14.1. Calculate the peak area of each OPNA in each calibration standard. 12.14.2. Calculate the peak area of each internal standard in each calibration standard. 12.14.3. Create a calibration curve using the concentration of each calibrant as the x-axis and RF as the y-axis. Calculate RF as follows:
where: A OPNA = Measured peak area of the phosphonic acid in the calibration standard. A IS = Measured peak area of the labelled phosphonic acid in the calibration standard. 
Title: Extraction of Phosphonic Acids from Urine Samples and Analysis by Gas Chromatography with Detection by Mass Spectrometry (GC-MS, GC-MS/MS) and Flame Photometric Detection (GC-FPD)
12.14.4. Calculate RF for each OPNA in each urine sample analyzed, using the corresponding deuterated phosphonic acid. If the appropriate stable isotope-labeled internal standards are not available, RF can be calculated based on the most similar labeled OPNA standard used (for example, MPA may be quantitated by referencing the D 5 -EMPA calibration). 12.14.5. Calculate the concentration in the sample using the calibration curve created above. 12.14.6. Correct concentration value for the concentration effect due to sample preparation. This corresponds to a factor of 10x for this current sample prep method.
METHOD PERFORMANCE:
13. 
